HIV Prevention and Treatment Research in Uganda through Johns Hopkins- Uganda Clinical Trial Unit
Official title: The Johns Hopkins University - Uganda Clinical Trials Unit
Funded at Johns Hopkins University · NIH-11603150 · Data updated 2026-11-12
A Johns Hopkins research group in Uganda is renewing support to run HIV prevention and treatment trials to help end the global HIV/AIDS epidemic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | February 5, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $150,000 |
| NIH project number | 3UM1AI069530-20S3 |
| Project ID | NIH-11603150 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include adults at high risk for HIV, people living with HIV needing advanced therapies, mothers and infants affected by HIV, and pediatric patients in HIV care.
✕Less likely to help
Some participants may not experience direct benefit from a given trial, or may contribute data without personal health improvements.
What this research studies
This program supports HIV-related clinical trials across Uganda, focusing on prevention of mother-to-child transmission, pediatric HIV treatment, and prevention among high-risk adults. It plans to expand with two new network affiliations and three new clinical research sites to reach diverse adult populations in Kampala and Rakai Districts. Researchers will collaborate with multiple DAIDS-funded HIV networks to study adult therapeutics, co-infections, maternal/adolescent/pediatric therapeutics, HIV prevention, and vaccines. The work involves enrolling participants, collecting health data, and testing interventions in real-world settings to advance treatment and prevention strategies for HIV.
Why it matters
Potential benefit: If successful, the research could improve HIV prevention and treatment options for diverse populations in Uganda and contribute to ending the HIV pandemic.
How similar studies have gone: Past work at JHU-CTU has shown progress in PMTCT and pediatric HIV treatment, with ongoing expansion planned for broader adult therapeutics and vaccines.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Fowler, Mary Glenn — Johns Hopkins University
- Study coordinator: Fowler, Mary Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.